Collegium Pharmaceutical Inc (STU:354)
€ 29.8 0.2 (0.68%) Market Cap: 968.63 Mil Enterprise Value: 1.67 Bil PE Ratio: 13.81 PB Ratio: 4.43 GF Score: 79/100

Collegium Pharmaceutical Inc at Needham Healthcare Conference Transcript

Apr 14, 2020 / 05:30PM GMT
Release Date Price: €17 (+0.59%)
Serge Belanger
Needham & Company - Analyst

Hi, good afternoon. I am Serge Belanger, one of the healthcare analysts at Needham. Thanks for dialing in or logging in to the 19th Annual Needham Conference. For our next session we have Collegium Pharmaceuticals. Paul Brannelly, the CFO, as well as Joe Ciaffoni, the CEO, are both with us to talk about Collegium. Gentlemen?

Paul Brannelly
Collegium Pharmaceutical, Inc. - EVP & CFO

Great, thanks, Serge. Before we begin today's fireside chat we want to remind everyone that none of the information presented today is intended to be promotional and that any forward-looking statements made today are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995.

You are cautioned that such forward-looking statements involve risks and uncertainties including and without limitation the risks that we may incur significant expense and may not prevail in current or future opioid industry litigation and investigations or other litigations pertaining to our products. These

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot